A review of mineral supplement formulations covering organic versus inorganic forms, comparative bioavailability, intracellular metabolic switching, and clinical applications. The paper covers zinc, selenium, copper, iron, and vanadium and addresses how the chemical form of a mineral supplement determines its bioavailability, metabolic fate, and therapeutic or toxic potential.
Key numbers
- Zinc bisglycinate: demonstrated higher bioavailability than zinc sulfate or zinc oxide in comparative studies; described as producing better tolerability and absorption at equivalent doses (p. 3-4).
- Zinc intracellular metabolic switching: intracellular zinc (Zn2+) activates or suppresses distinct signaling pathways depending on concentration; labile zinc pool regulates protein kinases, phosphatases, and transcription factors (p. 4).
- Selenium organic forms (selenomethionine, selenocysteine): better absorbed and retained than inorganic selenium (selenate, selenite); selenomethionine is non-specifically incorporated into proteins in place of methionine; selenocysteine is specifically incorporated into selenoproteins at UGA codons (p. 6-7).
- Copper-metallothionein interaction: metallothionein binds copper with higher affinity than zinc; excess zinc induces intestinal metallothionein expression, reducing copper absorption and producing secondary copper deficiency (p. 5).
- Vanadium insulin-mimetic effects: vanadium compounds (vanadate, vanadyl sulfate, bis-maltolato-oxovanadium) have demonstrated insulin-mimetic properties in animal models and small clinical trials, activating insulin receptor substrate pathways; evidence in humans is limited and vanadium’s essentiality in humans has not been established (p. 8-9).
- LOD/LOQ: not reported (review paper, no primary analytical measurements).
Methods (brief)
Narrative review on supplement formulation science. No systematic search protocol described. Because this is a review paper, LOD/LOQ, CRM use, and recovery data are not applicable.
Evidence fitness
This source supports the characterization of mineral bioavailability differences between organic and inorganic supplement forms, the mechanistic basis of zinc-copper antagonism via metallothionein, and the metabolic fate of selenium species. It does not provide food-matrix concentration data for finished food products. The vanadium insulin-mimetic evidence is limited to animal models and small human studies and does not establish vanadium as an essential element in humans.
Limitations
Narrative review without systematic search protocol. Bioavailability comparisons between mineral forms are drawn from studies of variable design; no pooled estimates are provided. The clinical evidence for vanadium is from small, non-definitive trials. The paper focuses on supplement formulations rather than dietary sources, limiting applicability to food-matrix analysis.
Related evidence
Update history
No substantive edit history is available in this build. The full commit record is available in git.